Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.

Criado MF, Bertran K, Lee DH, Killmaster L, Stephens CB, Spackman E, Sa E Silva M, Atkins E, Mebatsion T, Widener J, Pritchard N, King H, Swayne DE.

Vaccine. 2019 Apr 10;37(16):2232-2243. doi: 10.1016/j.vaccine.2019.03.009. Epub 2019 Mar 15.

2.

Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines.

Bertran K, Sá E Silva M, Pantin-Jackwood MJ, Swayne DE.

Vaccine. 2013 Aug 2;31(35):3572-6. doi: 10.1016/j.vaccine.2013.05.039. Epub 2013 May 23.

PMID:
23707445
3.

Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: pathobiology and vaccine protection.

Kapczynski DR, Pantin-Jackwood M, Guzman SG, Ricardez Y, Spackman E, Bertran K, Suarez DL, Swayne DE.

J Virol. 2013 Aug;87(16):9086-96. doi: 10.1128/JVI.00666-13. Epub 2013 Jun 12.

4.

Potency, efficacy, and antigenic mapping of H7 avian influenza virus vaccines against the 2012 H7N3 highly pathogenic avian influenza virus from Mexico.

Spackman E, Wan XF, Kapczynski D, Xu Y, Pantin-Jackwood M, Suarez DL, Swayne D.

Avian Dis. 2014 Sep;58(3):359-66.

PMID:
25518428
5.

Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18.

Chen HY, Shang YH, Yao HX, Cui BA, Zhang HY, Wang ZX, Wang YD, Chao AJ, Duan TY.

Antiviral Res. 2011 Jul;91(1):50-6. doi: 10.1016/j.antiviral.2011.04.007. Epub 2011 Apr 23.

PMID:
21549153
6.

Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18.

Mingxiao M, Ningyi J, Zhenguo W, Ruilin W, Dongliang F, Min Z, Gefen Y, Chang L, Leili J, Kuoshi J, Yingjiu Z.

Vaccine. 2006 May 15;24(20):4304-11. Epub 2006 Mar 29.

PMID:
16621199
7.

Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.

Swayne DE, Suarez DL, Spackman E, Jadhao S, Dauphin G, Kim-Torchetti M, McGrane J, Weaver J, Daniels P, Wong F, Selleck P, Wiyono A, Indriani R, Yupiana Y, Sawitri Siregar E, Prajitno T, Smith D, Fouchier R.

J Virol. 2015 Apr;89(7):3746-62. doi: 10.1128/JVI.00025-15. Epub 2015 Jan 21.

8.

Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.

Bertran K, Thomas C, Guo X, Bublot M, Pritchard N, Regan JT, Cox KM, Gasdaska JR, Dickey LF, Kapczynski DR, Swayne DE.

Vaccine. 2015 Jul 9;33(30):3456-62. doi: 10.1016/j.vaccine.2015.05.076. Epub 2015 Jun 9.

PMID:
26067184
9.

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF 3rd, Glenn GM.

Vaccine. 2013 Sep 13;31(40):4305-13. doi: 10.1016/j.vaccine.2013.07.043. Epub 2013 Jul 26.

11.

[Construction of recombinant fowlpox virus coexpressing HA from subtype H5 of avian influenza virus and chicken interleukin-18].

Chen H, Huang Q, Cui B, Li X, Guan Q.

Wei Sheng Wu Xue Bao. 2008 Aug;48(8):1025-30. Chinese.

PMID:
18956750
12.

[Construction of recombinant fowlpox virus coexpressing HA gene from H5N1 avian influenza virus and chicken interleukin-2 gene and assessment of its protective efficacy].

Yun SL, Zhang W, Liu WJ, Zhang XR, Chen SJ, Wu YT, Peng DX, Liu XF.

Bing Du Xue Bao. 2009 Nov;25(6):430-6. Chinese.

PMID:
20077933
13.

Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.

Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y.

Vaccine. 2015 Feb 25;33(9):1197-205. doi: 10.1016/j.vaccine.2014.12.028. Epub 2015 Jan 20.

14.
15.

Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.

Kim SM, Kim YI, Park SJ, Kim EH, Kwon HI, Si YJ, Lee IW, Song MS, Choi YK.

J Virol. 2017 Feb 28;91(6). pii: e01693-16. doi: 10.1128/JVI.01693-16. Print 2017 Mar 15.

16.

Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.

Pushko P, Tretyakova I, Hidajat R, Zsak A, Chrzastek K, Tumpey TM, Kapczynski DR.

Virology. 2017 Jan 15;501:176-182. doi: 10.1016/j.virol.2016.12.001. Epub 2016 Dec 6.

17.

Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.

Bublot M, Pritchard N, Cruz JS, Mickle TR, Selleck P, Swayne DE.

Avian Dis. 2007 Mar;51(1 Suppl):498-500.

PMID:
17494618
18.

[Recombinant fowlpox virus coexpressing HA and NA gene from subtype H5N1 of avian influenza virus and its protective efficacy].

Chen SJ, Sun L, Liu WJ, Sun XH, Liu XF.

Wei Sheng Wu Xue Bao. 2006 Feb;46(1):111-4. Chinese.

PMID:
16579476
19.

Development and use of fowlpox vectored vaccines for avian influenza.

Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC, Mickle TR.

Ann N Y Acad Sci. 2006 Oct;1081:193-201. Review.

PMID:
17135511
20.

Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.

Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.

J Virol. 2017 Sep 27;91(20). pii: e01202-17. doi: 10.1128/JVI.01202-17. Print 2017 Oct 15.

Supplemental Content

Support Center